SCHEMBL14686127

SCHEMBL14686127

Nc1ncnn2c(C3CCN(C(=O)O)C3)cc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYRO3 Q06418 6/20 0.52
FLT1 P17948 6/20 0.52
CSF1R P07333 5/20 0.52
AXL P30530 5/20 0.52
KIT P10721 5/20 0.52
GSK3B P49841 4/20 0.52
LCK P06239 4/20 0.52
LYN P07948 4/20 0.52
FLT3 P36888 4/20 0.52
BLK P51451 4/20 0.52
GSK3A P49840 3/20 0.52
PLK4 O00444 3/20 0.52
AURKA O14965 3/20 0.52
MAPK13 O15264 3/20 0.52
PDPK1 O15530 3/20 0.52
JAK2 O60674 3/20 0.52
CHEK2 O96017 3/20 0.52
NTRK1 P04629 3/20 0.52
MET P08581 3/20 0.52
FGFR1 P11362 3/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28776688 0.96 TYRO3 (0.54) TYRO3FLT1CSF1RAXLKIT
SCHEMBL59056 0.94 TYRO3 (0.55) TYRO3FLT1CSF1RAXLKIT
SCHEMBL5031566 0.93 FGFR1 (0.51) TYRO3FLT1CSF1RAXLKIT
SCHEMBL59234 0.91 TYRO3 (0.51) TYRO3FLT1CSF1RAXLKIT
SCHEMBL58316 0.90 TYRO3 (0.52) TYRO3FLT1CSF1RAXLKIT
SCHEMBL59352 0.89 TYRO3 (0.61) TYRO3FLT1CSF1RAXLKIT
SCHEMBL5036616 0.88 RET (0.52) TYRO3FLT1CSF1RAXLKIT
SCHEMBL59884 0.88 TYRO3 (0.54) TYRO3FLT1CSF1RAXLKIT
SCHEMBL65378 0.88 TYRO3 (0.52) TYRO3FLT1CSF1RAXLKIT
SCHEMBL60212 0.88 TYRO3 (0.55) TYRO3FLT1CSF1RAXLKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1957485-B1 SUBSTITUTED 4-AMINO-PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS BAYER HEALTHCARE LLC (US) 2013-02-13 EP claimed